FDA Approves Drug for Amylin’s diabetes Bydureon – Wall Street Journal

class = “lh”> approve Amylin’s Bydureon diabetes Drug
Wall Street Journal
By Peter Loftus, the U.S. Food and Drug Administration approved Amylin Pharmaceuticals Inc. ‘s diabetes Drug Bydureon ease after a long regulatory process in which the agency needs additional tests to safety concerns.
New York Times
size = diabetes drug gets FDA nod Fox News
WebMD